Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Advances in Enzyme Regulation
|
January 1, 1989
The phospholipid- and calcium-dependent protein kinase as a target in tumor chemotherapy
H Grunicke, J Hofmann, K Maly, et al.
Anti-Cancer Drug Design
|
July 1, 1995
Interference of new alkylphospholipid analogues with mitogenic signal transduction
K Maly, F Uberall, C Schubert, et al.
Advances in Enzyme Regulation
|
January 1, 1996
Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction
H H Grunicke, K Maly, F Uberall, et al.
The EMBO Journal
|
July 22, 1998
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta
S Kampfer, K Hellbert, A Villunger, et al.
The Journal of Biological Chemistry
|
July 15, 1989
Ha-ras activates the Na+/H+ antiporter by a protein kinase C-independent mechanism
K Maly, F Uberall, H Loferer, et al.
International Journal of Cancer
|
September 15, 1988
Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C
J Hofmann, W Doppler, A Jakob, et al.
Advances in Enzyme Regulation
|
June 1, 2000
Implication of atypical protein kinase C isozymes lambda and zeta in Ras mediated reorganization of the actin cytoskeleton and cyclin D1-induction
K Hellbert, S Kampfer, K Maly, et al.
The Journal of Biological Chemistry
|
February 14, 1997
Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts
F Uberall, S Giselbrecht, K Hellbert, et al.
Cancer Research
|
January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines
T Putz, Z Culig, I E Eder, et al.
The Journal of Biological Chemistry
|
June 19, 2001
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells
B Bauer, N Krumböck, F Fresser, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Advances in Enzyme Regulation
|
January 1, 1989
The phospholipid- and calcium-dependent protein kinase as a target in tumor chemotherapy
H Grunicke, J Hofmann, K Maly, et al.
Anti-Cancer Drug Design
|
July 1, 1995
Interference of new alkylphospholipid analogues with mitogenic signal transduction
K Maly, F Uberall, C Schubert, et al.
Advances in Enzyme Regulation
|
January 1, 1996
Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction
H H Grunicke, K Maly, F Uberall, et al.
The EMBO Journal
|
July 22, 1998
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta
S Kampfer, K Hellbert, A Villunger, et al.
The Journal of Biological Chemistry
|
July 15, 1989
Ha-ras activates the Na+/H+ antiporter by a protein kinase C-independent mechanism
K Maly, F Uberall, H Loferer, et al.
International Journal of Cancer
|
September 15, 1988
Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C
J Hofmann, W Doppler, A Jakob, et al.
Advances in Enzyme Regulation
|
June 1, 2000
Implication of atypical protein kinase C isozymes lambda and zeta in Ras mediated reorganization of the actin cytoskeleton and cyclin D1-induction
K Hellbert, S Kampfer, K Maly, et al.
The Journal of Biological Chemistry
|
February 14, 1997
Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts
F Uberall, S Giselbrecht, K Hellbert, et al.
Cancer Research
|
January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines
T Putz, Z Culig, I E Eder, et al.
The Journal of Biological Chemistry
|
June 19, 2001
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells
B Bauer, N Krumböck, F Fresser, et al.
Page
of 4